AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain
Status:
Completed
Trial end date:
2021-02-15
Target enrollment:
Participant gender:
Summary
This clinical trial evaluate the safety, tolerability and exploratory efficacy of targeted
single injection of AMG0103 in subject with chronic discogenic lumbar back pain